Skip to main content
SpringerLink
Log in

Coated-platelets correlate with disease progression in Alzheimer disease

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL (2000) Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen and convulxin. Blood 95:1694–1702

    PubMed  CAS  Google Scholar 

  2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. Washington DC

  3. Baskin F, Rosenberg RN, Iyer L, Hynan L, Cullum CM (2000) Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 54:1907–1909

    PubMed  CAS  Google Scholar 

  4. Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M (2002) [alpha]- Secretase ADAM10 as well as [alpha] APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8:67–74

    PubMed  CAS  Google Scholar 

  5. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L (2002) Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415:175–179

    Article  PubMed  CAS  Google Scholar 

  6. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–19

    Article  PubMed  CAS  Google Scholar 

  7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939–944

    PubMed  CAS  Google Scholar 

  8. Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, Perez J, Pettenati C, Mussi M, Parrinello G, Cottini E, Lenzi GL, Trabucchi M, Cattabeni F, Di Luca M (2001) Amyloid precursor protein in platelets - A peripheral marker for the diagnosis of sporadic AD. Neurology 57:2243–2248

    PubMed  CAS  Google Scholar 

  9. Padovani A, Borroni B, Colciaghi F, Pettenati C,Cottini E, Agosti C, Lenzi GL, CaltagironeC, Trabucchi M, Cattabeni F, Di Luca M (2002)Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 59:71–75

    Article  PubMed  Google Scholar 

  10. Prodan CI, Szasz R, Vincent AS, Ross ED, Dale GL (2006) Coated-platelets retain amyloid precursor protein on their surface. Platelets 17:56–60

    Article  PubMed  CAS  Google Scholar 

  11. Rosenberg RN, Baskin F, Fosmire JA, Risser R, Adams P, Svetlik D, Honig LS, Cullum CM, Weiner MF (1997) Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol 54:139–144

    PubMed  CAS  Google Scholar 

  12. Szasz R, Dale GL (2002) Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood 100:2827–2831

    Article  PubMed  CAS  Google Scholar 

  13. Szasz R, Dale GL (2003) COAT-platelets. Current Opinion Hematol 10:351–355

    Article  Google Scholar 

  14. Tang K, Hynan LS, Baskin F, Rosenberg RN (2006) Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci 240:53–58

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, University of Oklahoma Health Sciences Center, 711 S. L. Young Blvd., PPOB suite 215, Oklahoma City, OK, 73104, USA

    Calin I. Prodan & E. D. Ross

  2. Dept. of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    G. L. Dale

  3. Veterans Administration Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    Calin I. Prodan & E. D. Ross

  4. Center for the Study of Human Operator Performance, University of Oklahoma, Norman, OK, USA

    A. S. Vincent

Authors
  1. Calin I. Prodan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. D. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. S. Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. L. Dale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Calin I. Prodan.

Additional information

This work was supported in part by the National Institutes of Health (HL68129) to Dr. Dale. The authors are indebted to Sally Jett, Kimberly Peck, Bobbie Branscum, Matt Miller and Cris Thompson for their assistance with this project.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prodan, C.I., Ross, E.D., Vincent, A.S. et al. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 254, 548–549 (2007). https://doi.org/10.1007/s00415-006-0323-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0323-8

Keywords

Search

Navigation